Statins: New research explores muscle pain mechanisms and side effect risks

New research has provided a potential biological explanation for why some patients experience muscle pain while taking statins. A study conducted by researchers at the University of British Columbia and the University of Wisconsin–Madison, published in Nature Communications, suggests that statins may interfere with the RyR1 protein. This protein acts as a gate within muscle cells to control calcium release; the study found that drugs like atorvastatin may cause this gate to remain open, leading to a calcium leak that stresses muscle tissue.

In contrast, a large-scale study published in The Lancet involving over 123,000 individuals suggests that many commonly reported side effects may not be directly caused by the medication. The analysis of 19 clinical trials found no significant increased risk for conditions such as depression, sleep problems, fatigue, or headaches when comparing statins to a placebo.

Statins remain a primary treatment for lowering LDL cholesterol and preventing heart attacks and strokes. Medical professionals note that while clinicians select specific types—such as atorvastatin, fluvastatin, or simvastatin—based on individual risk, understanding the distinction between potential biological mechanisms for muscle pain and broader reported side effects is essential for patient care.